Economic evaluation of meningococcal vaccines: considerations for the future.

Christensen H, Al-Janabi H, Levy P, Postma MJ, Bloom DE, Landa P, Damm O, Salisbury DM, Diez-Domingo J, Towse AK, Lorgelly PK, et al. (2019)
The European journal of health economics : HEPAC : health economics in prevention and care.

Zeitschriftenaufsatz | E-Veröff. vor dem Druck| Englisch
 
Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Autor*in
Christensen, Hannah; Al-Janabi, Hareth; Levy, Pierre; Postma, Maarten J; Bloom, David E; Landa, Paolo; Damm, OliverUniBi; Salisbury, David M; Diez-Domingo, Javier; Towse, Adrian K; Lorgelly, Paula K; Shah, Koonal K
Alle
Abstract / Bemerkung
In 2018, a panel of health economics and meningococcal disease experts convened to review methodologies, frameworks, and decision-making processes for economic evaluations of vaccines, with a focus on evaluation of vaccines targeting invasive meningococcal disease (IMD). The panel discussed vaccine evaluation methods across countries; IMD prevention benefits that are well quantified using current methods, not well quantified, or missing in current cost-effectiveness methodologies; and development of recommendations for future evaluation methods. Consensus was reached on a number of points and further consideration was deemed necessary for some topics. Experts agreed that the unpredictability of IMD complicates an accurate evaluation of meningococcal vaccine benefits and that vaccine cost-effectiveness evaluations should encompass indirect benefits, both for meningococcal vaccines and vaccines in general. In addition, the panel agreed that transparency in the vaccine decision-making process is beneficial and should be implemented when possible. Further discussion is required to ascertain: how enhancing consistency of frameworks for evaluating outcomes of vaccine introduction can be improved; reviews of existing tools used to capture quality of life; how indirect costs are considered within models; and whether and how the weighting of quality-adjusted life-years (QALY), application of QALY adjustment factors, or use of altered cost-effectiveness thresholds should be used in the economic evaluation of vaccines.
Erscheinungsjahr
2019
Zeitschriftentitel
The European journal of health economics : HEPAC : health economics in prevention and care
eISSN
1618-7601
Page URI
https://pub.uni-bielefeld.de/record/2939275

Zitieren

Christensen H, Al-Janabi H, Levy P, et al. Economic evaluation of meningococcal vaccines: considerations for the future. The European journal of health economics : HEPAC : health economics in prevention and care. 2019.
Christensen, H., Al-Janabi, H., Levy, P., Postma, M. J., Bloom, D. E., Landa, P., Damm, O., et al. (2019). Economic evaluation of meningococcal vaccines: considerations for the future. The European journal of health economics : HEPAC : health economics in prevention and care. doi:10.1007/s10198-019-01129-z
Christensen, H., Al-Janabi, H., Levy, P., Postma, M. J., Bloom, D. E., Landa, P., Damm, O., Salisbury, D. M., Diez-Domingo, J., Towse, A. K., et al. (2019). Economic evaluation of meningococcal vaccines: considerations for the future. The European journal of health economics : HEPAC : health economics in prevention and care.
Christensen, H., et al., 2019. Economic evaluation of meningococcal vaccines: considerations for the future. The European journal of health economics : HEPAC : health economics in prevention and care.
H. Christensen, et al., “Economic evaluation of meningococcal vaccines: considerations for the future.”, The European journal of health economics : HEPAC : health economics in prevention and care, 2019.
Christensen, H., Al-Janabi, H., Levy, P., Postma, M.J., Bloom, D.E., Landa, P., Damm, O., Salisbury, D.M., Diez-Domingo, J., Towse, A.K., Lorgelly, P.K., Shah, K.K., Hernandez-Villafuerte, K., Smith, V., Glennie, L., Wright, C., York, L., Farkouh, R.: Economic evaluation of meningococcal vaccines: considerations for the future. The European journal of health economics : HEPAC : health economics in prevention and care. (2019).
Christensen, Hannah, Al-Janabi, Hareth, Levy, Pierre, Postma, Maarten J, Bloom, David E, Landa, Paolo, Damm, Oliver, Salisbury, David M, Diez-Domingo, Javier, Towse, Adrian K, Lorgelly, Paula K, Shah, Koonal K, Hernandez-Villafuerte, Karla, Smith, Vinny, Glennie, Linda, Wright, Claire, York, Laura, and Farkouh, Raymond. “Economic evaluation of meningococcal vaccines: considerations for the future.”. The European journal of health economics : HEPAC : health economics in prevention and care (2019).

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 31754924
PubMed | Europe PMC

Suchen in

Google Scholar